48,830
edits
Difference between revisions of "Intestinal spirochetosis"
Jump to navigation
Jump to search
no edit summary
| Line 13: | Line 13: | ||
| Molecular = | | Molecular = | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Grossing = | | Grossing = | ||
| Site = intestine - [[colon]] | | Site = intestine - [[colon]] | ||
| Line 24: | Line 24: | ||
| Bloodwork = | | Bloodwork = | ||
| Rads = | | Rads = | ||
| Endoscopy = | | Endoscopy = often normal | ||
| Prognosis = benign | | Prognosis = benign | ||
| Other = | | Other = | ||
| Line 43: | Line 43: | ||
Treatment:<ref name=pmid17914949>{{cite journal |author=Calderaro A, Bommezzadri S, Gorrini C, ''et al.'' |title=Infective colitis associated with human intestinal spirochetosis |journal=J. Gastroenterol. Hepatol. |volume=22 |issue=11 |pages=1772–9 |year=2007 |month=November |pmid=17914949 |doi=10.1111/j.1440-1746.2006.04606.x |url=}}</ref> | Treatment:<ref name=pmid17914949>{{cite journal |author=Calderaro A, Bommezzadri S, Gorrini C, ''et al.'' |title=Infective colitis associated with human intestinal spirochetosis |journal=J. Gastroenterol. Hepatol. |volume=22 |issue=11 |pages=1772–9 |year=2007 |month=November |pmid=17914949 |doi=10.1111/j.1440-1746.2006.04606.x |url=}}</ref> | ||
*Metronidazole. | *Metronidazole. | ||
==Gross== | |||
*Typically normal appearance. | |||
*Anatomical distribution in colon varies - may be absent in rectum.<ref>{{cite journal |authors=Walker MM, Talley NJ, Inganäs L, Engstrand L, Jones MP, Nyhlin H, Agréus L, Kjellstrom L, Öst Å, Andreasson A |title=Colonic spirochetosis is associated with colonic eosinophilia and irritable bowel syndrome in a general population in Sweden |journal=Hum Pathol |volume=46 |issue=2 |pages=277–83 |date=February 2015 |pmid=25540866 |doi=10.1016/j.humpath.2014.10.026 |url=}}</ref> | |||
==Microscopic== | ==Microscopic== | ||